Arete Wealth Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Arete Wealth Advisors's LLY Position: Q1 2026 in Review
Arete Wealth Advisors sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 5,387 shares — an estimated $5.79M sold.
Arete Wealth Advisors first reported a position in LLY in Q4 2020 and held it in 19 quarters. The position peaked at $1.39B in Q4 2022. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Arete Wealth Advisors reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
- Arete Wealth Advisors sold 5,387 Eli Lilly shares in Q1 2026, an estimated $5.79M.
- Arete Wealth Advisors first reported a position in Eli Lilly in Q4 2020 and held it in 19 quarters.
- Arete Wealth Advisors's Eli Lilly position peaked at $1.39B in Q4 2022.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Arete Wealth Advisors's 13F filing for Q1 2026, filed 18 May 2026.